NNIT NNIT A/S

NNIT A/S: A CHALLENGING THIRD QUARTER. NECESSARY ACTIONS TAKEN TO IMPROVE PERFORMANCE IN 2024 AND LONG-TERM

NNIT A/S: A CHALLENGING THIRD QUARTER. NECESSARY ACTIONS TAKEN TO IMPROVE PERFORMANCE IN 2024 AND LONG-TERM

Q3 2024 key highlights

  • Financial performance for the third quarter was unsatisfactory. Some areas of the business did not perform as initially planned in Region US and Region Europe which negatively impacted the performance. Organic growth was negative by 1.6% and total revenue growth was negative by 1.7%. In Q3 2023, Region DK revenue was impacted by a positive technical one-off due to the carve-out of around DKK 15m as a revenue accrual was released in the quarter despite being related to previous quarters. Adjusted for this, the underlying organic growth for the Group would have been 1.7% and total growth of 1.6%
  • Group operating profit margin excl. special items was 3.9% for the quarter. The unfavorable development in the profit margin was due to lower topline performance and as a consequence of NNIT having too much capacity
  • To improve business performance, necessary actions were taken to reduce capacity in the relevant areas in Region Europe and Region US on top of the initiatives carried out in the first half of the year
  • Full-year financial outlook was adjusted on 22 Oct 2024 cf. company announcement 7. The adjusted full-year outlook is an organic growth around 6 to 7% (previously around 10%) and group operating profit margin excl. special items between 6 to 7% (previously between 8 to 9%)

The third quarter was more challenging than anticipated. Despite positive momentum in the first half of the year, including several levers initiated in Q2 to accelerate profitability, organic growth and group operating profit margin excl. special items decreased in Q3 2024 compared with last year. A moderate slowdown in the Life Science market caused projects to be postponed or paused and resulted in lower growth than anticipated for Region US and Region Europe. In addition, recovery in the data migration business progressed at a slower pace than anticipated.

Although the performance in the third quarter was unsatisfactory, a pick-up in growth and profitability is expected in Q4 driven by a high backlog coverage, the effects of the profitability levers initiated in the second and third quarter, improvement in utilization of billable employees, and additional adjustments made to align internal capacity with market demand carried out in the beginning of Q4.

Financial overview - Selected key figures

NNIT GROUP, DKK millionQ3 2024Q3 20239M 20249M 2023FY 2023
Revenue444.7452.61,382.11,2891,728
Revenue growth, %-1.7%19.1%7.2%16.8%15.2%
Revenue growth, organic %-1.6%11.1%5.6%11.3%10.8%
Group operating profit excl. special items17.526.573.472116
Group operating profit margin excl. special items, %3.9%5.8%5.3%5.6%6.7%
Special items9.416.013.361.069
Group operating profit incl. special items8.110.560.11147
Group operating profit margin incl. special items, %1.8%2.3%4.3%0.8%2.7%



CONFERENCE CALL

November 6, 2024, at 9:30 AM CET:

Dial in information:

DK:

SE:

UK: 9

US:

Participant Access code: 472855

CONTACT

For more information, please contact:

Investor Relations

Carsten Ringius

EVP & CFO

Tel:

Media Relations

Tina Joanne Hindsbo

Media Relations Manager

Tel:

ABOUT NNIT

NNIT is a leading provider of IT solutions to life sciences internationally, and to the public and private sectors in Denmark.

We focus on high complexity industries and thrive in environments where regulatory demands and complexity are high.

We advise on and build sustainable digital solutions that work for the patients, citizens, employees, end users or customers.

We strive to build unmatched excellence in the industries we serve, and we use our domain expertise to represent a business first approach – strongly supported by a selection of partner technologies, but always driven by business needs rather than technology.

NNIT consists of group company NNIT A/S and subsidiaries SCALES, Excellis Health Solutions and SL Controls. Together, these companies employ more than 1,700 people in Europe, Asia, and USA. Read more at .

Attachment



EN
05/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NNIT A/S

ABGSC IT Research ... (+2)
  • ABGSC IT Research
  • Mikkel Kousgaard Rasmussen
 PRESS RELEASE

NNIT A/S: Resolutions from the annual general meeting of NNIT A/S

NNIT A/S: Resolutions from the annual general meeting of NNIT A/S Today, NNIT A/S held its annual general meeting, at which the following were noted/approved: Financial year 2024 and 2025 The Chairman of the Board gave the Board of Directors’ report on the Company’s activities in the past financial year, especially highlighting: NNIT is now a highly specialized IT consultancy firm with a focus on Life Sciences internationally and the public sector in Denmark.Revenue growth has been higher than the market despite lowered financial expectations during the year.Several new customers have ...

ABGSC IT Research ... (+2)
  • ABGSC IT Research
  • Mikkel Kousgaard Rasmussen
 PRESS RELEASE

NNIT A/S: Notice convening the annual general meeting for NNIT A/S

NNIT A/S: Notice convening the annual general meeting for NNIT A/S The Board of Directors gives notice of the annual general meeting for NNIT A/S, company registration (CVR) no. 21 09 31 06 (the “Company”), to be held Thursday, March 13, 2025, 2:00 pm (CET) at Novo Holdings A/S, Tuborg Havnevej 19, DK-2900 Hellerup. The general meeting will for shareholders be webcasted live on the Company’s investor portal. It is not possible to vote or ask questions via webcast. The notice for the annual general meeting, including Appendix A: Candidates for (re-)election to the Board of Directors, is at...

ABGSC IT Research ... (+2)
  • ABGSC IT Research
  • Mikkel Kousgaard Rasmussen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch